27.09.2014 Views

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

SIN-1 resulted in an 8.6 fold increase in SN compared to CI-1044 alone, and a 4.6<br />

fold increase from SIN-1 alone. Mesenteric and periarterial inflammation in the<br />

CI-1044 group was increased compared to vehicle controls, L-NAME or SIN-1<br />

groups. Mild arterial fibrinoid necrosis was also present in a subset <strong>of</strong> animals<br />

treated with CI-1044. Co-administration <strong>of</strong> CI-1044 and L-NAME resulted in reduced<br />

mesenteric and periarterial inflammation compared to CI-1044 alone.<br />

Furthermore, arterial medial injury was not noted. Co-administration <strong>of</strong> CI-1044<br />

and SIN-1 resulted in a marked increase in mesenteric arterial injury and inflammation<br />

compared to SIN-1 or CI-1044 alone. <strong>The</strong> present study suggests a link between<br />

NO modulation and DIVI. Future studies will be aimed at further defining<br />

the pathogenesis <strong>of</strong> this unique type <strong>of</strong> injury.<br />

1745 INVOLVEMENT OF SHEAR STRESS IN FENOLDOPAM<br />

AND DOPAMINE INDUCED MESENTERIC MEDIAL<br />

ARTERIAL NECROSIS.<br />

D. Dalmas, M. Scicchitano, K. Roland, D. Mullins, T. Chordia, K. Frazier and<br />

H. Thomas. Safety Assessment, GlaxoSmithKline, King <strong>of</strong> Prussia, PA.<br />

Extrapolation and relevance <strong>of</strong> drug-induced rodent vascular injury to humans has<br />

hampered drug development due to lack <strong>of</strong> understanding <strong>of</strong> the pathologic mechanisms<br />

involved. Although vasodilatation & increased shear stress (SS) have been<br />

hypothesized to be involved in the pathogenesis <strong>of</strong> these lesions, the exact role <strong>of</strong> SS<br />

on primary target cells, smooth muscle (SMC) and endothelial cells (EC) in vivo<br />

remain unclear. Dopaminergic DA1 agonists such as Fenoldopam and Dopamine<br />

reproducibly induce mesenteric medial arterial necrosis (MAN) in rats following<br />

single vasotoxic doses. To investigate the involvement <strong>of</strong> SS in the development <strong>of</strong><br />

MAN, rats were given vehicle, Dopamine or Fenoldopam for 4 days followed by<br />

necropsy 24 hours later. Yohimbine, an α2 adrenoreceptor antagonist, also vasoactive<br />

but lacking MAN histologic lesions, was given to rats for 4 days for comparison.<br />

To evaluate the timecourse <strong>of</strong> lesion development, rats were also given vehicle<br />

or a single vasotoxic dose <strong>of</strong> Fenoldopam and necropsied 1-, 4-, 6-, 12- or 24 hours<br />

postdose. Mesentery from each rat was collected and frozen in OCT, then EC and<br />

SMC were microdissected from sections <strong>of</strong> mesenteric arteries <strong>of</strong> each rat, and<br />

RNA was amplified and analyzed. Regulation <strong>of</strong> 37 shear stress responsive genes<br />

were evaluated using TaqMan gene expression pr<strong>of</strong>iling. Many <strong>of</strong> the genes evaluated<br />

were confirmed to be differentially expressed by Dopamine and Fenoldopam<br />

in EC- and/or SMC-enriched samples as compared to controls or Yohimbine following<br />

4 daily doses. A number <strong>of</strong> SS responsive genes were also shown to be differentially<br />

regulated beginning 1- and/or 4-hours post-Fenoldopam treatment and<br />

prior to histological evidence <strong>of</strong> MAN (which was initially observed beginning at<br />

12-hours). Evaluation <strong>of</strong> this panel <strong>of</strong> genes has provided evidence <strong>of</strong> the involvement<br />

and regulation <strong>of</strong> SS responsive genes in both EC and SMC during the development<br />

<strong>of</strong> Dopamine and Fenoldopam-induced vascular injury.<br />

every timepoint analyzed except recovery animals. EMPs with phenotypes <strong>of</strong><br />

CD45-CD42d-CD31+CD54+, CD45-CD42d-CD31+CD146+, CD45-CD42d-<br />

CD54+CD146+ and CD45-CD42d-CD106+Flk-1+ were increased significantly<br />

24 hours after drug treatment and correlated with histopathology data. EMP levels<br />

dropped to baseline levels after 10 days <strong>of</strong> recovery. <strong>The</strong> present study suggests that<br />

EMPs potentially represent a novel biomarker for DIVI observed in preclinical<br />

species.<br />

1747 A NOVEL MECHANISM FOR ALCOHOLIC<br />

CARDIOMYOPATHY: SUPEROXIDE GENERATION IS A<br />

PIVOTAL MEDIATOR FOR SUPPRESSION OF GAPDH<br />

THAT TRIGGERS CARDIAC IMBALANCE OF ENERGY<br />

UTILIZATION, OXIDATIVE STRESS, AND<br />

REMODELING.<br />

Y. Tan 1 , Z. Zhou 2 and L. Cai 1 . 1 Pediatrics, University <strong>of</strong> Louisville, Louisville, KY<br />

and 2 Medicine, University <strong>of</strong> Louisville, Louisville, KY.<br />

We tried to define whether ethanol may induce NADPH oxidase-dependent superoxide<br />

that inhibits GAPDH, thereby diverting upstream metabolites from glycolysis<br />

into pathways <strong>of</strong> glucose overutilization, resulting in an imbalance <strong>of</strong> glucose<br />

and fatty acid utilization, cardiac oxidative stress and structural remodeling. Male<br />

C57/BL6 mice were pair-fed an alcohol or isocaloric maltose dextrin liquid diet for<br />

two months. Chronic alcohol feeding caused a significant increase in NADPH oxidase<br />

expression and a decrease in GAPDH expression, and also caused a cardiac<br />

glucose overutilization, shown by increased GSK-3β phosphorylation and hexokinase<br />

II expression, and fatty acid metabolism disorder, evidenced by increased<br />

PPARα (a positive mediator for fatty acid uptake and utilization) and decreased<br />

PGC-1α (an essential regulator for the optimal cardiac mitochondrial fatty acid oxidation).<br />

<strong>The</strong> imbalanced energy utilization was associated with significant increases<br />

in cardiac oxidative damage, shown by 3-nitrotyrosine accumulation, cell<br />

death and neutrophil infiltration, and cardiac remodeling, mirrored by cardiac hypertrophy<br />

and fibrosis (TGF-β1 and CTGF expression). To define the critical role<br />

<strong>of</strong> superoxide, cardiac H9c2 cells were treated with 2.5% (v/v) ethanol for 120<br />

hours, which induced significant oxidative damage, cell death, and fibrosis, as observed<br />

in the hearts <strong>of</strong> alcoholic mice. However, pre-incubation <strong>of</strong> cells with superoxide<br />

dismutase mimetic significantly attenuated ethanol-decreased GAPDH expression,<br />

along with improvement <strong>of</strong> the above described pathogenic changes.<br />

<strong>The</strong>refore, alcohol activation <strong>of</strong> NADPH oxidase-related superoxide generation<br />

plays a critical role in depressing GADPH expression. <strong>The</strong> decreased expression and<br />

function <strong>of</strong> GAPDH may be the key mediator leading to cardiac imbalance <strong>of</strong> glucose<br />

and fatty acid utilization, oxidative damage, inflammation and remodeling<br />

that eventually results in alcoholic cardiomyopathy.<br />

1746 IDENTIFICATION AND ANALYSIS OF CIRCULATING<br />

ENDOTHELIAL MICROPARTICLES AS A POTENTIAL<br />

BIOMARKER OF DRUG-INDUCED VASCULAR INJURY.<br />

B. Enerson, C. Conley, C. Huang, M. Kate and S. Sokolowski. Drug Safety<br />

Research and Development, Pfizer Global Research and Development, Groton, CT.<br />

Sponsor: M. Lawton.<br />

<strong>The</strong> finding <strong>of</strong> acute drug-induced vascular injury (DIVI) in preclinical toxicity<br />

studies <strong>of</strong>ten leads to delays in, or termination <strong>of</strong>, drug development projects because<br />

the relevance <strong>of</strong> this finding to humans is unclear. Furthermore, there are no<br />

sensitive and specific DIVI biomarkers that readily translate into a clinical setting.<br />

Endothelial microparticles (EMPs) are small vesicles that are released from endothelial<br />

cells into circulating blood and are found at elevated levels in a number <strong>of</strong><br />

human diseases associated with vascular or endothelial dysfunction. <strong>The</strong> purpose <strong>of</strong><br />

this study was to identify and quantify by flow cytometry circulating EMPs in<br />

plasma <strong>of</strong> rats treated with phosphodiesterase 4 (PDE4) inhibitor CI-1044. In this<br />

time-course study, platelet-poor plasma (PPP) was collected from male Sprague<br />

Dawley rats (5/time point) 4, 8, 16, and 24 hours following a single dose, 24 hours<br />

following either 2 or 3 daily doses, and 10-days following 3 daily doses <strong>of</strong> 80<br />

mg/kg/day CI-1044. Detection <strong>of</strong> EMPs in PPP was accomplished using markers<br />

specific for endothelial cells (CD31, CD106, CD146, CD54, Flk-1, vWF).<br />

Additional exclusion markers (CD45 and CD42d) and the apoptotic marker<br />

Annexin V were included to further characterize the origin <strong>of</strong> microparticles. All<br />

stained PPP samples were processed concurrently with microbeads to set a baseline<br />

for size and EMPs were identified based on size and labeling with specific markers.<br />

Administration <strong>of</strong> CI-1044 to rats resulted in increased plasma levels <strong>of</strong> EMPs at<br />

1748 POLYCHLORINATED BIPHENYL INDUCED VCAM-1<br />

EXPRESSION IS ABOLISHED IN AORTIC<br />

ENDOTHELIAL CELLS ISOLATED FROM CAVEOLIN-1<br />

DEFICIENT MICE.<br />

S. Han 1 , M. Toborek 2 and B. Hennig 1 . 1 Animal and Food Sciences, University <strong>of</strong><br />

Kentucky, Lexington, KY and 2 Department <strong>of</strong> Neurosurgery, University <strong>of</strong> Kentucky,<br />

Lexington, KY.<br />

Environmental chemical contaminants, such as polychlorinated biphenyls (PCBs)<br />

are known to be atherogenic in human and the underlying mechanism is becoming<br />

elucidated. Vascular cell adhesion molecule-1 (VCAM-1) is a critical mediator for<br />

adhesion and uptake <strong>of</strong> monocytes in the initial stage <strong>of</strong> atherosclerosis development<br />

in endothelium. PCBs may be proatherogenic by causing upregulation <strong>of</strong><br />

VCAM-1. Caveolae are particularly abundant in endothelial cell membrane and are<br />

involved in trafficking and signal transduction. <strong>The</strong> objective <strong>of</strong> this study was to<br />

investigate the role <strong>of</strong> caveolae in PCB-induced endothelial cell dysfunction.<br />

Primary mouse aortic endothelial cells (MAECs) isolated from caveolin-1 deficient<br />

mice and background C57BL/6 mice were treated with coplanar PCBs, such as<br />

PCB77 and PCB126. In addition, siRNA gene silencing technique was used to<br />

knockdown caveolin-1 in porcine vascular endothelial cells. Expression <strong>of</strong> VCAM-<br />

1 was observed as a proatherogenic marker in cells. Both coplanar PCBs increased<br />

mRNA and protein levels <strong>of</strong> VCAM-1 and number <strong>of</strong> adhered monocytes in<br />

porcine endothelial cells. In MAECs, VCAM-1 mRNA and protein levels were increased<br />

after exposure to both coplanar PCBs in cells with caveolin-1, whereas not<br />

significantly altered in cells absent caveolin-1. Furthermore, number <strong>of</strong> adhered<br />

monocyte was significantly increased by PCB exposure only in caveolin-1 containing<br />

MAECs. Similarly, caveolin-1 silencing using siRNA technique in porcine en-<br />

372 SOT 2010 ANNUAL MEETING

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!